{
    "organizations": [],
    "uuid": "b75634ab6566ffed0a954f65644f574ea26f5b21",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/gsk-ma-pharmaceuticals/gsk-grabs-roche-cancer-expert-to-lead-pharma-pipeline-deals-idUSL8N1RV47H",
    "ord_in_thread": 0,
    "title": "GSK grabs Roche cancer expert to lead pharma pipeline deals",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "LONDON, April 18 (Reuters) - GlaxoSmithKline said on Wednesday it had hired Kevin Sin from Rocheâ€™s Genentech unit to head worldwide business development for pharmaceuticals research and development.\nSin, who will join GSK in San Francisco in July, has been responsible for oncology deal-making at Genentech since 2010. He will play a pivotal role as the British drugmaker seeks to strengthen its drug pipeline through acquisitions and licensing deals. (Reporting by Ben Hirschler, editing by Louise Heavens)\n ",
    "published": "2018-04-18T21:25:00.000+03:00",
    "crawled": "2018-04-19T15:06:47.000+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "london",
        "april",
        "reuters",
        "glaxosmithkline",
        "said",
        "wednesday",
        "hired",
        "kevin",
        "sin",
        "roche",
        "genentech",
        "unit",
        "head",
        "worldwide",
        "business",
        "development",
        "pharmaceutical",
        "research",
        "development",
        "sin",
        "join",
        "gsk",
        "san",
        "francisco",
        "july",
        "responsible",
        "oncology",
        "genentech",
        "since",
        "play",
        "pivotal",
        "role",
        "british",
        "drugmaker",
        "seek",
        "strengthen",
        "drug",
        "pipeline",
        "acquisition",
        "licensing",
        "deal",
        "reporting",
        "ben",
        "hirschler",
        "editing",
        "louise",
        "heaven"
    ]
}